Marshall Wace
CRBU icon

Marshall Wace’s Caribou Biosciences CRBU Stock Holding History

Marshall Wace’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
1,205,668
+324,563
+37% +$557K ﹤0.01% 1709
2025
Q4 		$1.4M Buy
881,105
+755,261
+600% +$1.59M ﹤0.01% 1768
2025
Q3 		$293K Buy
+125,844
New +$238K ﹤0.01% 2436
2024
Q3 		– Sell
-164,948
Closed -$271K – 2576
2024
Q2 		$271K Sell
164,948
-203,309
-55% -$650K ﹤0.01% 2194
2024
Q1 		$1.89M Buy
368,257
+310,527
+538% +$1.91M ﹤0.01% 1392
2023
Q4 		$331K Buy
+57,730
New +$285K ﹤0.01% 1860

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return